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© 2013 Japanese Society of Tropical MedicineAbstr ct: Introduction: The World Health Organization (WHO) recommends HIV Counseling and Testing (HCT)
in a range of clinical settings. We describe the characteristics of patients diagnosed with HIV on the medical and
surgical wards at a tertiary care hospital in Malawi.
Methods: Under the universal opt-out HCT protocol we characterized the number of new HIV/AIDS infections
and associated clinical features among hospitalized surgical and medical patients diagnosed during the course of
admission.
Results: All 2985 and 3959 medical and surgical patients, respectively, admitted between April 2012 and January
2013 were screened for HCT. 62% and 89% of medical and surgical patients, respectively, had an unknown status
on admission and qualified for testing. Of the patients with an unknown status, a new HIV diagnosis was made
in 20% and 7% of medical and surgical patients, respectively. Of the newly diagnosed patients with a CD4 count
recorded, 91% and 67% of medical and surgical patients, respectively, had a count less than 350, qualifying for
ART by Malawi ART guidelines. Newly HIV-diagnosed medical and surgical patients had an inpatient mortality
of 20% and 2%, respectively.
Discussion: While newly diagnosed HIV-positive medical patients had high inpatient mortality and higher rates of
WHO stage 3 or 4 conditions, surgical patients presented with less advanced HIV, though still meeting ART ini-
tiation guidelines. The medical inpatient wards are an obvious choice for implementing voluntary counseling and
testing (VCT), but surgical patients present with less advanced disease and starting treatment in this group could
result in more years of life gained.
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INTRODUCTION
HIV and AIDS more heavily affect Sub-Saharan
Africa than any other region of the world, with an estimated
22.9 million people living with HIV in the region [1]. In
2010 around 1.9 million people became infected with HIV
and 1.2 million people died from AIDS in sub-Saharan
Africa. Achieving universal access to treatment, prevention
and care is predicated upon attaining universal knowledge
of HIV status [1]. In Malawi, 11% of the general adult pop-
ulation has HIV, and higher rates are observed among high-
risk populations, including 71% of sex workers [2]. Despite
this high prevalence, 27% of women and 48% of men in
Malawi have never been tested for HIV [3]. HIV counseling
and testing (HCT) is recognized as a pivotal entry point for
the prevention, treatment and care of HIV. The goal of HCT
is to promote self-awareness of HIV status [4]. HCT alone
has been shown to decrease high-risk behaviors [5], and
earlier diagnosis is associated with a longer life expectancy
[6].
The Malawi Ministry of Health (MOH) guidelines in
2011 state that HTC should be offered to all patients with an
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unknown or undocumented status presenting to a health
care facility for any reason [7], and several studies have
shown increased identification of HIV-positive patients
through the HTC implemented in various settings [8–11].
Though the majority of sub-Saharan African countries have
developed similar policies, few have been able to fully im-
plement HTC in all settings, and most previous research has
been in antenatal clinics [12, 13]. In a study from Malawi,
HIV-infected patients comprise 28% of medical inpatients
[14], and in a study from South Africa, 33% of surgical pa-
tients offered HTC tested positive [8]. A decade ago, 91%
of medical and 56% of surgical patients tested positive in
Blantyre, Malawi [15]. Medical patients tested under uni-
versal opt-out protocols were found to have advanced dis-
ease by World Health Organization (WHO) staging criteria
in 70% of cases [9], while a similar study of surgical pa-
tients showed that only 24% had advanced disease [10].
Comparisons of current WHO staging criteria and
CD4 counts between medical and surgical patients have not
been delineated, and while universal HCT in all health-care
settings is recommended, it is not routine in many parts of
sub-Saharan Africa [13]. Few previous studies have focused
on surgical patients [10, 11], and only one study from a de-
cade ago compares medical and surgical patients [15].
Therefore, we sought to determine the number of new HIV
infections diagnosed under the universal opt-out HTC pro-
tocol at Kamuzu Central Hospital (KCH) in medical and
surgical patients. We also sought to describe associated clin-
ical and demographic characteristics. We examined CD4
counts, discharge diagnosis, and outcome to determine dif-
ferences between HIV-positive medical and surgical inpa-
tients.
METHODS
Study setting and population
KCH is a 750-bed tertiary care hospital in Lilongwe,
Malawi with a catchment population of over 5 million peo-
ple in the central region of the country. Since November
2011, the standard procedure for HIV testing on the KCH
medicine and surgical wards includes counselor initiated,
universal opt-out HIV testing as has been described previ-
ously [11]. At admission, HIV counselors approach all
newly admitted patients and evaluate for evidence of previ-
ous HIV testing. All patients with no documented HIV test
results or documented negative test dated older than three
months are offered and receive HIV counseling and testing
unless they explicitly refuse. HIV testing results are re-
corded according to required MOH guidelines and shared
with treating clinicians through documentation in the pa-
tient file.
The study population consisted of adult medical and
surgical inpatients that were eligible for HCT. We included
all adult medical and surgical inpatients screened for HIV
counseling and testing and described characteristics of
those newly diagnosed with HIV during hospitalization at
KCH from April 2012 to January 2013 in this analysis.
Study Design
This is a retrospective observational study of prospec-
tively collected data. Demographics, clinical characteris-
tics, admitting and discharge diagnoses, HIV status and test
results, and inpatient mortality are abstracted from medical
and surgical patient charts and entered into an Access data-
base.
We first describe the HIV status, age, sex, and admis-
sion diagnosis distribution of all persons presenting for
care. For the main analyses, we included patients who had
unknown HIV status on admission or a negative test dated
older than three months, who tested positive. Per protocol at
KCH, a CD4 count and WHO staging is performed for all
adult patients newly diagnosed with HIV.
Data Analysis
Demographics and clinical characteristics of the gen-
eral medical and surgical populations were compared.
Newly diagnosed HIV-positive medical and surgical pa-
tients were compared with respect to CD4 count, discharge
diagnosis, and inpatient mortality. For newly diagnosed
HIV-positive patients without recorded WHO staging on the
intake forms, WHO 3 or 4 criteria was abstracted from the
discharge diagnosis. Surgical diagnoses coded in our data-
base and meeting these criteria included osteomyelitis, sep-
tic joint, Kaposi sarcoma, pyomyositis, extra-pulmonary
Fig. 1. CD4 counts in medicine and surgery patients with a
new HIV diagnosis at KCH
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TB, and empyema. Medical diagnoses coded in our data-
base and meeting these criteria included chronic (> 1
month) gastroenteritis, Kaposi sarcoma, meningitis, oral or
esophageal candidiasis, pneumonia, and pulmonary or ex-
tra-pulmonary tuberculosis.
Categorical variables were compared between settings
using Person’s chi-square test, and continuous variables
were analyzed using the t-test. Odds ratios and 95% confi-
dence intervals comparing medical and surgical patients for
inpatient mortality, discharge diagnosis meeting WHO 3 or
4 criteria, discharge diagnosis of infection, and CD4 counts
less than 350 were calculated using logistic regression. Ad-
justed odds ratios were controlled for age and sex, unless
otherwise specified. Data were analyzed using Stata 12.
Both the National Health Science Research Council of
Malawi and the University of North Carolina Internal
Review Board approved this study.
RESULTS
Patient Population
During the study period 6944 patients were screened
for HCT, including 2985 medical patients and 3959 surgical
patients. Medical patients were on average 2 years older
than surgical patients, and females comprised a greater por-
tion of medical patients (Table 1).
The most common diagnoses among surgical patients
were trauma (n = 1476, 37%), while the most common diag-
noses among medical patients were pneumonia (n = 448,
16%), malaria (n = 382, 13%), and anemia (n = 381, 13%)
(Table 2).
HIV Counseling and Testing
Of the 2985 medical and 3959 surgical patients
screened for HCT, 1857 (62%) medical patients and 3506
(89%) surgical patients had an unknown HIV status or neg-
ative test dated older than three months on admission and
Table 1. Characteristics of medical and surgical patients at KCH
* Outcome data are missing for 60 medical patients and 407 surgical patients, therefore percentages are
based on totals excluding missing patients.
Characteristic
Medicine (n = 2985) 
n (%) or mean (SD)
Surgery (n = 3959) 
n (%) or mean (SD)
p value
Demographics
Age 39.7 (16.6) 37.6 (19.3) < 0.001
18–25 years 590 (20%) 1,093 (28%)
26–35 years 831 (29%) 935 (24%)
36–50 years 814 (28%) 876 (23%)
51–65 years 389 (13%) 586 (15%)
65+ years 281 (10%) 372 (10%)
Sex
Male 1653 (56%) 2711 (69%) < 0.001
Female 1325 (44%) 1653 (31%)
Hospital Course
Admitting Diagnosis
Infection 1189 (41%) 537 (14%) < 0.001
Non infection 1664 (59%) 3410 (86%)
Outcome
Discharge 2199 (75%) 3135 (89%) < 0.001
Death 674 (22%) 111 (3%)
Abscond 62 (2%) 286 (8%)
HIV Counseling and Testing Results
HIV status
Known positive 933 (31%) 230 (6%) < 0.001
Known negative 195 (7%) 223 (6%)
Tested positive 224 (8%) 159 (4%)
Tested negative 915 (31%) 2107 (53%)
Unknown/not tested 718 (24%) 1240 (31%)
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qualified for testing (Table 1). Of the 5363 patients with an
unknown HIV status on admission, 1139 (61%) medical and
2266 (65%) surgical patients received HIV testing during
their hospital admission. Nineteen (1%) medical patients
and 59 (2%) surgical patients declined testing. Other pa-
tients died or were discharged before testing was offered, or
the counselor was unable to locate the patient.
Demographics of Newly Diagnosed HIV-positive
Patients
A new diagnosis of HIV infection was made in 224
(20%) medical and 159 (7%) surgical patients who under-
went testing. In total, 1157 (39%) medical and 389 (10%)
surgical patients were HIV-positive, either diagnosed prior
to admission or diagnosed through the HCT protocol. Of the
total number of HIV-positive medical patients, 224 (19%)
were newly diagnosed under the inpatient HCT protocol,
whereas 81% had a prior diagnosis. Of all HIV-positive sur-
gical patients, 159 (41%) were newly diagnosed under the
inpatient HCT protocol, while 59% had an HIV diagnosis
prior to admission. The mean age of the newly diagnosed
medical and surgical patients was 36.7 and 34.5 years, re-
spectively. The majority of newly diagnosed medical (54%)
and surgical (65%) patients were male. Significantly more
medical patients had WHO Stage 3 or 4 diseases recorded as
discharge diagnoses in their charts at the time of admission
(50% vs. 5%) (Table 3).
As with the background surgical inpatient population,
the most common discharge diagnosis in surgical patients
with a new HIV diagnosis was trauma (n = 58, 38%). Simi-
lar to the background medical patient population, the most
common diagnoses in medical patients with a new HIV di-
agnosis were pneumonia (n = 59, 27%) and malaria (n = 40,
18%). (Table 2)
CD4 Count Analysis
Requests for CD4 counts were documented in all but
four patients; however, only 25% (n = 56) and 36% (n = 58)
of medical and surgical patients, respectively, had a CD4
count obtained and recorded in the patient chart (Table 4).
Medical patients were less likely to have a CD4 count ob-
tained and recorded (AOR 0.6, CI: 0.4–0.9). Patients with a
Table 2. Discharge diagnosis and outcome among all patients and newly diagnosed HIV+ patients on the
surgical and medical wards at KCH
* Diagnosis is not specified in 14 surgical patients (including 4 surgical patients with new HIV diagnosis,
and in 133 medical patients (including 15 medical patients with new HIV diagnosis). Missing data are ex-
cluded when calculating percentages. Additionally, 596 surgical patients (including 19 surgical patients
with a new HIV diagnosis) and 1138 medical patients (including 76 medical patients with a new HIV di-
agnosis) have more than one discharge diagnosis listed. Therefore, percentages of patients with each diag-
nosis do not add to 100%.
All Surgical patients 
(N = 3959)
Newly diagnosed HIV + 









Trauma 1476 (37%) 45 (3%) 58 (38%) 1 (2%)
Bowel Obstruction 266 (7%) 15 (6%) 15 (10%) 0  —
Skin/soft tissue infection 225 (6%) 2 (1%) 12 (8%) 0  —
Cancer 188 (5%) 7 (4%) 1 (1%) 0  —
UGI Bleeding 143 (4%) 8 (6%) 5 (3%) 0  —
Sub-acute abdominal pain 132 (3%) 4 (3%) 4 (3%) 0  —
Total 3959  — 111 (3%) 159  — 4 (3%)
All medical patients 
(N = 2985)
Newly diagnosed HIV+ 









Pneumonia 448 (16%) 113 (25%) 59 (28%) 10 (17%)
Malaria 382 (13%) 46 (12%) 40 (19%) 8 (20%)
Anemia 381 (13%) 99 (26%) 18 (9%) 5 (28%)
Acute gastroenteritis 257 (9%) 30 (12%) 26 (12%) 3 (12%)
CHF 227 (8%) 62 (27%) 6 (3%) 2 (33%)
Meningitis 135 (5%) 45 (33%) 19 (9%) 8 (42%)
Total 2985  — 674 (23%) 224  — 44 (20%)
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discharge diagnosis meeting WHO stage 3 or 4 criteria were
slightly, though not significantly less likely to have a CD4
count obtained and recorded (AOR: 0.7, CI: 0.4–1.1).
The mean CD4 counts in newly diagnosed medical and
surgical HIV-positive patients were 168 and 331 cells/μL,
respectively. The CD4 count did not differ significantly be-
tween male and female patients (p = 0.4) or between pa-
tients who were admitted for management of an infectious
versus non-infectious complaint (p = 0.1). However, there
was a statistically significant difference in the mean CD4
count among patients with an admission diagnosis that met
WHO stage 3 or 4 disease and those without, 137 and 301
cells/μL, respectively (p = 0.001).
HIV Staging and ART Eligibility
WHO stage 3 or 4 disease or CD4 count less than 350
cells/μL are the eligibility criteria for starting antiretroviral
treatment in Malawi. Of the 114 newly positive patients
with a CD4 count, 51 (91%) of medical and 33 (57%) of
surgical patients were found to be less than 350 cells/μL. Of
all newly diagnosed patients, 132 (61%) medical and 40
(25%) surgical patients met criteria for ART initiation, ei-
ther by CD4 count or WHO stage 3 or 4 disease by dis-
charge diagnosis. Of the 132 medical and 40 surgical pa-
tients eligible for ART, CD4 count less than 350 cells/μL
was the determining criterion for 20 (15%) medical patients
and 33 (83%) surgical patients who did not have a discharge
diagnosis meeting WHO 3 or 4 criteria.
Table 3. Comparison of medicine to surgery patients with a new HIV diagnosis at KCH
* Outcome data is missing for 7 surgical patients and 20 medical patients, therefore percentages are based
on totals excluding missing patients.
Characteristic Medicine (n = 224) Surgery (n = 159) p-value
Demographics
Age in years
Mean (std dv) 36.7 (12.8) 34.5 (11.9) 0.09
18–25 years 37 (17%) 34 (22%)
26–35 years 92 (42%) 61 (39%)
36–50 years 63 (29%) 49 (31%)
51–65 years 18 (8%) 12 (8%)
65+ years 10 (5%) 2 (1%)
Sex
Male 122 (54%) 103 (65%)
Female 102 (46%) 56 (35%) 0.04
CD 4 Count and WHO Staging Criteria
CD4 count obtained
Yes 56 (25%) 58 (36%)
No 168 (75%) 101 (64%) 0.02
CD4 count
> 350 5 (9%) 25 (43%)
< 350 51 (91%) 33 (67%) < 0.001
< 200 39 (70%) 23 (40%) 0.001
Abstraction of WHO criteria
WHO Stage 3 or 4 105 (50%) 8 (5%)
Not WHO Stage 3 or 4 104 (50%) 146 (95%) < 0.001
Hospital Course
Admitting diagnosis
Infection 167 (80%) 31 (19%)
Non infection 42 (20%) 127 (81%) < 0.001
Outcome
Discharge 170 (78%) 134 (96%)
Death 44 (20%) 3 (2%)
Abscond 3 (2%) 2 (2%) < 0.001
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Mortality Analysis
Newly diagnosed HIV-positive medical patients also
had a higher in-hospital mortality than newly diagnosed
HIV-positive surgical patients (Table 3). Among the 44
medical patients with a new HIV diagnosis who died on ad-
mission, meningitis, pneumonia, presumed sepsis, and ma-
laria were the most common diagnoses. Three surgical pa-
tients died, one who was admitted for trauma and two with
unrecorded or undetermined admitting diagnoses. Eight pa-
tients with a recorded CD4 count died during admission, in-
cluding seven medical patients and one surgical patient, all
of whom had a count less than 350 cells/μL and seven of
whom had a count less than 200 cells/μL. Patients with a fi-
nal diagnosis meeting criteria for WHO stage 3 or 4 diagno-
sis were significantly more likely to die on admission (AOR
3.4, CI: 1.8–6.4). Outcome data were missing for 7 medical
and 20 surgical patients with a new HIV diagnosis.
DISCUSSION
In our study, surgical patients with a new HIV diagno-
sis had less advanced disease by CD4 count, and less inpa-
tient mortality, than medical patients. The majority of med-
ical and surgical inpatients with a new HIV diagnosis qual-
ified for ART by Malawi MOH guidelines, and surgical pa-
tients were more likely to qualify based on CD4 count
rather than having a discharge diagnosis meeting WHO 3 or
4 criteria.
The discharge diagnoses for newly identified HIV-
positive patients in the surgical and medical wards were
similar to the discharge diagnoses in the background popu-
lations on these wards respectively, with a few exceptions.
A greater percentage of newly diagnosed HIV-positive pa-
tients had meningitis compared with all medical inpatients,
and fewer newly diagnosed HIV-positive medical patients
had congestive heart failure compared with all surgical in-
patients. Additionally, fewer surgical patients with a new
HIV diagnosis had cancer than the background surgical in-
patient population. This is likely a reflection of age, as
newly diagnosed HIV medical and surgical patients were
generally younger than the general inpatient population.
Early HIV diagnosis provides an opportunity to im-
prove the health of not only the individual patient, but also
the population as a whole. HCT alone reduces high-risk be-
haviors [5], and anti-retroviral therapy (ART) reduces trans-
mission of HIV [16]. Starting ART before the CD4 count
falls below 200 cells/μL results in nearly double the years of
life gained from treatment than implementing ART at CD4
counts below 200 cells/μL [17], and starting ART before the
CD4 count falls below 350 cells/μL results in further de-
creases in mortality and incident tuberculosis than starting
at a threshold of 200 cells/μL [18]. However, advanced pre-
sentation at the time of diagnosis is common [19], obviating
these benefits.
Though the Malawi Ministry of Health recommends
HCT be offered to a patient presenting to a health care facil-
ity for any reason [Malawi guidelines], nearly half of men
and a quarter of women in Malawi have never been tested
for HIV [2]. In our study, medical patients with a new HIV
diagnosis had lower CD4 counts, more advanced HIV, and
Table 4. Comparison of outcomes, CD4 counts, and diagnoses between medicine and surgery patients
with a new HIV diagnosis at KCH
* Adjusted for age and sex
Crude OR CI Adjusted OR* CI
Outcome
Survived 1 1
Died 7.41 2.86–19.14 7.21 2.77–18.78
CD4 Count
CD4 not obtained 1 1
CD4 obtained 0.58 0.37–0.90 0.59 0.38–0.93
CD4 > 350 1 1
CD4 < 350 7.27 2.69–22.20 7.80 2.60–23.44
CD4 > 200 1 1
CD4 < 200 3.49 1.61–7.58 3.25 1.45–7.28
Admitting Diagnosis
Non-infectious 1 1
Infection 13.97 8.43–23.16 14.93 8.83–25.23
Not meeting WHO stage 3 or 4 criteria 1 1
WHO state 3 or 4 criteria 18.43 8.60–39.46 19.01 8.80–41.07
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higher inpatient mortality than surgical patients, consistent
with previous studies [13]. Although fewer surgical patients
tested positive, HTC in the surgical population presents a
unique opportunity to identify patients with less advanced
HIV who can expect more years of life gained from ART
than patients with more advanced HIV. While few patients
in our study declined testing, more than half of newly diag-
nosed HIV-positive patients presented with advanced HIV
by WHO 3 or 4 criteria and CD4 count, and were likely
symptomatic. Whether these patients declined previous
testing or lacked access to testing before admission is an im-
portant area for future research to optimize delivery of HTC
services.
According to Malawi MOH guidelines for 2011, both
clinical and laboratory guidelines can be used to determine
ART eligibility. All newly diagnosed HIV-positive patients
with WHO stage 3 or 4 disease qualify for ART and do not
require a CD4 count for ART initiation, while patients with
WHO stage 1 or 2 disease require a CD4 count to determine
eligibility. In our population, surgical patients with a new
HIV diagnosis infrequently met WHO stage 3 or 4 criteria
by discharge diagnosis, and the vast majority of surgical pa-
tients eligible for ART met eligibility because of a CD4
count less than 350 cells/μL. In contrast, half of newly diag-
nosed medical patients met WHO 3 or 4 criteria by dis-
charge diagnosis, and few patients met ART eligibility
based on CD4 count alone. Surgical patients were more
likely to have a CD4 count obtained and recorded in the
medical chart, which is consistent with the recommendation
that CD4 counts be obtained in WHO stage 1 and 2 patients
but not in WHO stage 3 or 4 patients.
Though CD4 counts are more likely to determine ART
initiation in surgical patients, CD4 counts are more likely to
determine clinical management of the acute diagnosis in
medical patients. Therefore, obtaining a CD4 count can be
important for clinical decision-making in both groups, but
obtaining and recording a CD4 count remained a challenge
in both medical and surgical wards. Challenges include the
availability of personnel, blood collection tubes and nee-
dles, and an operational CD4 count machine with rapid
turnaround time and communication of the results. Point-of-
care testing for CD4 counts has been shown to be accurate
[20] and to reduce loss to follow-up [21, 22] in patients with
newly diagnosed HIV and could result in better clinical
management of these patients.
This study is limited by the incomplete record of WHO
staging and CD4 counts. We attempted to abstract those di-
agnoses which met criteria for stage 3 or 4 disease, but inci-
dental candidiasis or Kaposi sarcoma may not be recorded,
and WHO stage could therefore be underestimated. Addi-
tionally, more than a third of patients who qualified for HCT
and did not decline testing were not tested. Patients were of-
ten discharged or died before testing, or were lost on the
wards.
In our setting, HCT identified more new HIV infec-
tions in medical patients, who typically presented with ad-
vanced disease. However, the majority of both medical and
surgical patients met criteria for ART initiation by CD4
count, though surgical patients were much less likely to
have a diagnosis meeting criteria for WHO stage 3 or 4 dis-
ease. Improved CD4 count implementation could identify
particularly more surgical patients who qualify for ART.
Though the medical inpatient wards are an obvious choice
for implementing VCT, surgical patients present with less
advanced disease, and starting treatment in this group could
result in more years of life gained.
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